keyword
https://read.qxmd.com/read/37792211/an-in-vitro-study-of-the-impacts-of-sweet-potato-chips-with-potentially-probiotic-levilactobacillus-brevis-and-lactiplantibacillus-plantarum-on-human-intestinal-microbiota-impacts-of-potato-chips-with-probiotics-on-intestinal-microbiota
#21
JOURNAL ARTICLE
Tarsila Gonçalves Feitoza, Bárbara de Lima Ponciano Costa, Karoliny Brito Sampaio, Marcos Dos Santos Lima, Estefânia Fernandes Garcia, Thatyane Mariano Rodrigues de Albuquerque, Evandro Leite de Souza, Noádia Priscila Araújo Rodrigues
This study formulated sweet potato chips with powdered potentially probiotic Levilactobacillus brevis (SPLB) and Lactiplantibacillus plantarum (SPLP) and evaluated their impacts on human intestinal microbiota during 48 h of in vitro colonic fermentation. L. brevis and L. plantarum kept high viable cell counts (> 6 log CFU/g) on sweet potato chips after freeze-drying and during 60 days of storage. SPLB and SPLP had satisfactory quality parameters during 60 days of storage. SPLB and SPLP increased the relative abundance of Lactobacillus ssp...
October 4, 2023: Probiotics and Antimicrobial Proteins
https://read.qxmd.com/read/37788391/significant-geographic-variation-in-access-to-certified-collagenase-clostridium-histolyticum-injectors-for-peyronie-s-disease-throughout-the-united-states
#22
JOURNAL ARTICLE
Michael Sischka, Alexander Krueger, Niki Parikh, Tobias Kohler, Sevann Helo, Matthew Ziegelmann
INTRODUCTION: We characterize the geographic distribution of providers trained to inject Clostridium histolyticum and identify areas with low provider availability. METHODS: We utilized a publicly available search tool to identify clinical sites offering Clostridium histolyticum in the U.S. The data gathered included the provider's name, specialty, address, and whether the site was considered high-volume (ie, administer ≥20 Clostridium histolyticum injections per year)...
September 7, 2023: Urology Practice
https://read.qxmd.com/read/37753943/peyronie-s-disease-response-to-intralesional-collagenase-clostridium-histolyticum-therapy-is-independent-of-baseline-testosterone
#23
JOURNAL ARTICLE
Douglas Schneider, Mitchell O'Leary, Eliad Amini, Jake Miller, Nick Hassas, Jeanie Nguyen, Muhammed A Moukhtar Hammad, David Barham, Faysal A Yafi
BACKGROUND: Testosterone plays an important role in collagen metabolism, transforming growth factor-β1 expression, and wound healing, which are all critical factors in pathogenesis of Peyronie's disease. Some clinical studies have suggested an association between Peyronie's disease and hypogonadism. OBJECTIVE: We sought to investigate whether baseline total testosterone levels influence response to intralesional collagenase clostridium histolyticum in Peyronie's disease...
September 27, 2023: Andrology
https://read.qxmd.com/read/37724612/revealing-the-beneficial-effects-of-a-dairy-infant-formula-on-the-gut-microbiota-of-early-childhood-children-with-autistic-spectrum-disorder-using-static-and-shime%C3%A2-fermentation-models
#24
JOURNAL ARTICLE
Louise Iara Gomes de Oliveira, Jéssika Rodrigues Clementino, Mateus Kawata Salgaço, Sônia Paula Alexandrino de Oliveira, Marcos Dos Santos Lima, Victoria Mesa, Evandro Leite de Souza, Celso Gabriel Vinderola, Marciane Magnani, Katia Sivieri
This study evaluated the impact of the Milnutri Profutura® (MNP) dairy infant formula on the gut microbiota of early childhood children (three to five years) with Autistic Spectrum Disorder (ASD) using static fermentation (time zero, 24, and 48 h) and the Simulator of the Human Intestinal Microbiol Ecosystem (SHIME®) (time zero, 72 h, and 7 days). The relative abundance of selected intestinal bacterial groups, pH values, organic acids, and sugars were verified at time zero, 24, and 48 h using flow cytometry and measurements...
October 2, 2023: Food & Function
https://read.qxmd.com/read/37691710/can-you-go-the-distance-collagenase-clostridium-histolyticum-manipulation-at-1-month-after-injection
#25
Lacey R Pflibsen, Nirbhay S Jain, Prosper Benhaim
Collagenase Clostridium histolyticum is a popular treatment in Dupuytren contracture. Current guidelines are for manipulation 24 hours to 7 days after injection. We present a case of successful manipulation 28 days after injection.
September 2023: Plastic and Reconstructive Surgery. Global Open
https://read.qxmd.com/read/37665353/collagenase-clostridium-histolyticum-injection-versus-limited-fasciectomy-for-the-treatment-of-dupuytren-s-disease-a-systematic-review-and-meta-analysis-of-comparative-studies
#26
REVIEW
Rémy Liechti, Dominique Nellie Merky, Damian Sutter, Ramin Ipaktchi, Esther Vögelin
INTRODUCTION: The aim of the present study is to systematically review the literature on well-selected comparative studies for meta-analysis on outcome differences between collagenase clostridium histolyticum (CCH) injection and limited fasciectomy (LF) for Dupuytren's disease. MATERIALS AND METHODS: PubMed/Medline, Embase, and the Cochrane Library were searched for comparative studies assessing differences in outcomes of CCH and LF. Effect estimates were pooled across studies using random effects models and presented as weighted mean difference (MD) and odds ratio (OR) with corresponding 95% confidence interval (CI)...
September 4, 2023: Archives of Orthopaedic and Trauma Surgery
https://read.qxmd.com/read/37626834/in-vitro-study-of-a-novel-vibrio-alginolyticus-based-collagenase-for-future-medical-application
#27
JOURNAL ARTICLE
Lindsey Alejandra Quintero Sierra, Reetuparna Biswas, Alice Busato, Anita Conti, Riccardo Ossanna, Giamaica Conti, Nicola Zingaretti, Michele Caputo, Christian Cuppari, Pier Camillo Parodi, Andrea Sbarbati, Michele Riccio, Francesco De Francesco
Mesenchymal stem cells extracted from adipose tissue are particularly promising given the ease of harvest by standard liposuction and reduced donor site morbidity. This study proposes a novel enzymatic method for isolating stem cells using Vibrio alginolyticus collagenase, obtaining a high-quality product in a reduced time. Initially, the enzyme concentration and incubation time were studied by comparing cellular yield, proliferation, and clonogenic capacities. The optimized protocol was phenotypically characterized, and its ability to differentiate in the mesodermal lineages was evaluated...
August 8, 2023: Cells
https://read.qxmd.com/read/37626201/insurance-approval-rates-for-collagenase-clostridium-histolyticum-prior-to-discontinuation-a-canada-wide-analysis
#28
JOURNAL ARTICLE
David Chung, Benjamin Shiff, Dhiraj S Bal, Thomas Southall, Ruben Blachman-Braun, Marc Grenier, Ryan Flannigan, Premal Patel
Collagenase Clostridium histolyticum (CCh), the first approved non-surgical treatment for Peyronie's disease (PD), was withdrawn from the European, Canadian, and Asian markets due to poor demand and lack of government reimbursement options. We sought to assess insurance approval rates and usage of CCh across Canada to understand the factors that led to its withdrawal. Data on patients prescribed CCh for PD or Dupuytren's contracture was obtained through collaboration with BioScript Solutions to assess the association of variables with insurance approval and prescription filling...
August 25, 2023: International Journal of Impotence Research
https://read.qxmd.com/read/37624871/comparison-of-patient-demographics-utilization-trends-and-costs-of-treatment-for-dupuytren-s-disease-in-the-united-states-from-2012-to-2019
#29
JOURNAL ARTICLE
Adam M Gordon, Patrick P Nian, Chaim Miller, Jake M Schwartz, Jack Choueka
INTRODUCTION: Dupuytren's disease is a fibroproliferative disorder of the palm leading to flexion deformities of the digits that impair hand function. Studies have evaluated treatment trends for patients with Dupuytren's disease; however, most conclude in 2012 shortly after collagenase clostridium histolyticum (CCH) injection was introduced to the market. It is unknown how provider preferences have been influenced since its introduction. We aimed to compare treatment options with regard to (1) patient demographics, (2) annual utilization rates, and (3) costs...
August 21, 2023: Annals of Plastic Surgery
https://read.qxmd.com/read/37610395/assessing-the-effect-of-time-from-injection-of-collagenase-to-manipulation-on-success-rates-in-dupuytren-disease
#30
JOURNAL ARTICLE
Purushottam Nagarkar, Nirbhay S Jain, Meaghan L Barr, Cathy Tang, Dong Lee, Irene Chang, Michael R Delong, Prosper Benhaim
PURPOSE: Dupuytren disease can be managed with an injection of collagenase Clostridium histolyticum enzyme followed by manual manipulation. Although the recommended time from injection to manipulation is 24-72 hours, patient and physician schedules may not accommodate this time frame. Therefore, we sought to study the impact of time from injection to manipulation on outcomes and complications of collagenase injection. METHODS: We performed a review of 309 patients who underwent an injection of collagenase Clostridium histolyticum for Dupuytren disease with manipulation at two, five, or seven days after injection...
August 21, 2023: Journal of Hand Surgery
https://read.qxmd.com/read/37593783/current-trends-in-non-surgical-management-of-peyronie-s-disease-a-narrative-review
#31
REVIEW
Anna Kozub, Agata Suleja, Marcin Chłosta, Andrzej Kupilas, Benjamin Pradere, Juan Gómez Rivas, Paweł Rajwa, Marcin Miszczyk
Peyronie's disease (PD) is a connective tissue disorder affecting the tunica albuginea. It can cause pain and penile deformation, and its prevalence increases with age. Although surgery is the gold standard for the chronic phase of the disease, there are several conservative treatment methods available, and the optimal management of the acute phase of the disease remains a matter of debate. In this article, we aim to summarize the recent trends in research on the subject of non-surgical treatment of PD. The search was performed in PubMed, Scopus, and Web of Science databases and included studies in English published between 2012 and 2022 investigating the clinical outcomes of non-surgical PD management in humans...
August 18, 2023: Andrology
https://read.qxmd.com/read/37561381/revealing-the-potential-impacts-of-nutraceuticals-formulated-with-freeze-dried-jabuticaba-peel-and-limosilactobacillus-fermentum-strains-candidates-for-probiotic-use-on-human-intestinal-microbiota
#32
JOURNAL ARTICLE
Jaielison Yandro Pereira da Silva, Heloísa Maria Almeida do Nascimento, Thatyane Mariano Rodrigues de Albuquerque, Karoliny Brito Sampaio, Marcos Dos Santos Lima, Mariana Monteiro, Iris Batista Leite, Evandro Ferreira da Silva, Yuri Mangueira do Nascimento, Marcelo Sobral da Silva, Josean Fechine Tavares, José Luiz de Brito Alves, Maria Elieidy Gomes de Oliveira, Evandro Leite de Souza
This study evaluated the impacts of novel nutraceuticals formulated with freeze-dried jabuticaba peel (FJP) and three potentially probiotic Limosilactobacillus fermentum strains on the abundance of bacterial groups forming the human intestinal microbiota, metabolite production, and antioxidant capacity during in vitro colonic fermentation. The nutraceuticals had high viable counts of L. fermentum after freeze-drying (≥ 9.57 ± 0.09 log CFU/g). The nutraceuticals increased the abundance of Lactobacillus ssp...
August 10, 2023: Probiotics and Antimicrobial Proteins
https://read.qxmd.com/read/37529412/new-considerations-in-the-use-of-collagenase-clostridium-histolyticum-for-the-treatment-of-cellulite
#33
JOURNAL ARTICLE
Jeremy A Grekin, Joel L Cohen, Michael S Kaminer
No abstract text is available yet for this article.
2023: Aesthetic surgery journal. Open forum
https://read.qxmd.com/read/37524836/in-vitro-efficacy-of-intralesional-collagenase-clostridium-histolyticum-for-the-treatment-of-calcified-peyronie-s-disease-plaques
#34
JOURNAL ARTICLE
Alexandra Dullea, Kajal Khodamoradi, Katherine Campbell, Armin Ghomeshi, Ranjith Ramasamy, Matthew Ziegelmann, Thomas Masterson
Peyronie's disease (PD) is defined by penile plaque formation and curvature causing sexual dysfunction. The only FDA-approved intralesional treatment is Collagenase Clostridium histolyticum (CCh). CCh contains two collagenases, AUX1 and AUXII, that break down the type I and type III collagen contained in plaques, leading to plaque dissolution and reduction in penile curvature. Peyronie's plaques, however, also contain fibrin and calcium, which CCh cannot digest. It is unclear if plaque calcification prevents CCh from breaking down plaques...
July 31, 2023: International Journal of Impotence Research
https://read.qxmd.com/read/37520321/identification-of-novel-gene-signatures-and-immune-cell-infiltration-in-intervertebral-disc-degeneration-using-bioinformatics-analysis
#35
JOURNAL ARTICLE
Tao Tang, Zhongyuan He, Zhengya Zhu, Fuan Wang, Hongkun Chen, Fu Zhang, Jiaxiang Zhou, Jianmin Wang, Baoliang Li, Xizhe Liu, Zhiyu Zhou, Shaoyu Liu
Background: Intervertebral disc degeneration (IDD) is the leading cause of lower back pain, and an overall understanding of the molecular mechanisms related to IDD is still lacking. The purpose of this study was to explore gene signatures and immune cell infiltration related to IDD via bioinformatics analysis. Methods: A total of five expression profiles of mRNA and non-coding RNA were downloaded from the Gene Expression Omnibus (GEO) database. The potentially involved lncRNA/circRNA-miRNA-mRNA networks and protein-protein interaction networks were constructed by miRNet, circBank, STRING, and the Cytoscape database...
2023: Frontiers in Molecular Biosciences
https://read.qxmd.com/read/37480917/targeting-myofibroblasts-as-a-treatment-modality-for-dupuytren-disease
#36
JOURNAL ARTICLE
Mary E Ziegler, Andres Staben, Melinda Lem, Jason Pham, Leonardo Alaniz, Faris F Halaseh, Sabine Obagi, Amber Leis, Alan D Widgerow
PURPOSE: Currently, no treatment corrects the contractile nature of Dupuytren myofibroblasts (DMFs) or prevents recurrence following surgery. Antifibrotic and proadipogenic growth factors are released when adipose-derived stem cells (ASCs) are cultured with platelet-rich plasma (PRP), a platelet concentration from whole blood. Reprograming myofibroblasts into adipocytes via growth factors is proposed as a powerful potential tool to target fibrosis. We aimed to assess whether the combination of ASCs and PRP reprograms DMFs into adipocytes in vitro and alters their contractile nature in vivo...
July 19, 2023: Journal of Hand Surgery
https://read.qxmd.com/read/37468535/a-contemporary-assessment-of-the-evaluation-and-management-of-patients-presenting-to-a-tertiary-medical-center-with-peyronie-s-disease
#37
JOURNAL ARTICLE
Daniel Roadman, Vinson Wang, Adam Beer, Laurence Levine
Peyronie's disease continues to be poorly understood. We characterize the presenting features of Peyronie's disease within a large cohort and elucidate the factors that correlate with surgical intervention. Univariate and multivariate analyses were performed on 1483 consecutive patients to assess pre-operative predictors of surgical intervention for Peyronie's disease. Overall, 1263 patients met inclusion criteria. Mean age was 55.4 ± 11.1 years with a mean duration of disease at presentation of 33...
July 19, 2023: International Journal of Impotence Research
https://read.qxmd.com/read/37388561/validation-of-a-handprint-for-clinical-evaluation-of-dupuytren-s-contracture
#38
JOURNAL ARTICLE
Takashi Ajiki, Akira Murayama, Yukinori Hayashi, Katsushi Takeshita
Objective  We have developed a handprint-based method for visualizing and quantifying the palmar contact of patients with Dupuytren's contracture. The purpose of this study was to examine whether the generated handprint was useful for assessing the severity of flexion contracture of the fingers and for evaluating the therapeutic effects of collagenase clostridium histolyticum (CCH) injection for Dupuytren's contracture. Methods  The handprint was created by applying medical-grade ethanol-containing hand sanitizer over the entire palmar surface of the affected hand and then pressing it on thermal paper for word processors...
June 2023: Journal of Hand and Microsurgery
https://read.qxmd.com/read/37369062/a-critical-analysis-of%C3%A2-dupuytren-s-contracture-recurrence-following-collagenase-clostridium-histolyticum-injection
#39
JOURNAL ARTICLE
Seungkyu B Park, Usmaan Al-Shehab, Ashley Sundin
No abstract text is available yet for this article.
June 27, 2023: Military Medicine
https://read.qxmd.com/read/37366388/expanded-utilization-of-intralesional-therapies-for-treatment-of-peyronie-s-disease
#40
REVIEW
Prajit Khooblall, Raevti Bole, Scott D Lundy, Petar Bajic
PURPOSE: In this narrative review we explore additional indications for which intralesional collagenase Clostridium histolyticum (CCH) injection therapy may be used, in addition to those utilized in the IMPRESS trials. The goal is to provide updated assessment of available intralesional therapies and justify whether to expand clinical indications based on advancements over the last decade. RESULTS: Patients receiving CCH in the acute phase of PD have shown significant improvement in penile curvature - which may be even more significant than reported due to progressive curvature over the longitudinal course of injection therapy...
2023: Research and Reports in Urology
keyword
keyword
163313
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.